NCT03953612View on ClinicalTrials.gov

The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

May 8, 2023

Study Completion Date

May 8, 2023

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Pregnenolone (PREG)

2 doses of PREG (300 or 500 mg/day)

DRUG

Placebos

placebo

Trial Locations (1)

06519

Yale Stress Center, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03953612 - The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders | Biotech Hunter | Biotech Hunter